Ditchcarbon
  • Contact
  1. Organizations
  2. Idexx Laboratories
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Idexx Laboratories Sustainability Profile

Company website

IDEXX Laboratories, Inc., a leading innovator in the veterinary diagnostics industry, is headquartered in the United States. Founded in 1983, the company has established itself as a key player in the development of diagnostic products and services for animal health, water testing, and dairy testing. With a strong presence in North America, Europe, and Asia, IDEXX is renowned for its advanced diagnostic technologies, including the IDEXX VetLab® suite and the SNAP® test platform. The company’s commitment to enhancing animal health and welfare is reflected in its core offerings, which include laboratory services, point-of-care diagnostics, and software solutions. IDEXX's unique approach combines cutting-edge technology with a deep understanding of veterinary needs, positioning it as a trusted partner in the industry. Notable achievements include a robust market share and recognition for its contributions to improving pet care and public health.

DitchCarbon Score

How does Idexx Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Idexx Laboratories's score of 30 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.

50%

Let us know if this data was useful to you

Idexx Laboratories's reported carbon emissions

In 2024, IDEXX Laboratories reported total greenhouse gas emissions of approximately 38,697,000 kg CO2e, with Scope 2 emissions accounting for about 20,236,000 kg CO2e. This marks an increase from 2023, when total emissions were about 35,015,000 kg CO2e, with Scope 2 emissions at approximately 18,557,000 kg CO2e. Over the past few years, IDEXX has demonstrated a commitment to reducing its carbon footprint, setting a target to decrease its Scope 1 and 2 greenhouse gas emissions by 37.8% by 2030, based on 2021 levels. The company has consistently reported emissions data, focusing on Scope 1 and 2, while not disclosing Scope 3 emissions. In 2021, IDEXX's emissions were approximately 34,027,000 kg CO2e, with Scope 1 emissions at about 16,646,000 kg CO2e and Scope 2 emissions at around 17,381,000 kg CO2e. The trend indicates a need for enhanced strategies to meet their ambitious reduction targets. IDEXX's climate commitments reflect a proactive approach to sustainability, aligning with industry standards for greenhouse gas management. The company's emissions data is sourced directly from IDEXX Laboratories, Inc., ensuring accuracy and transparency in their reporting.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2017201920202021202220232024
Scope 1
-
00,000,000
00,000,000
00,000,000
-
-
-
Scope 2
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-

How Carbon Intensive is Idexx Laboratories's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Idexx Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Idexx Laboratories's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Idexx Laboratories is in US, which has a low grid carbon intensity relative to other regions.

Idexx Laboratories's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Idexx Laboratories has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Idexx Laboratories's Emissions with Industry Peers

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Patterson Companies, Inc.

US
•
Health and social work services (85)
Updated 8 days ago

VCA Inc.

US
•
Food waste for treatment: composting and land application
Updated 28 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Abbott Diagnostics GmbH

DE
•
Other business services (74)
Updated about 2 months ago

Sgs

CH
•
Other services (93)
Updated 7 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy